Davangere Sugar Company Share Price Today

Davangere Sugar AGM approves USD 100m overseas investment limit

Shareholders approved overseas investments up to USD 100 million. Issuance of 10,64,11,079 convertible equity warrants to promoters approved. Audited financial statements for FY26 adopted at the 55th AGM. Authorized share capital increase and MoA alteration sanctioned.

Davangere Sugar schedules 55th AGM for September 12, 2026

Davangere Sugar Company Limited holds its 55th AGM on September 12, 2026. Remote e-voting runs from September 9 to September 11, 2026. Record date for voting eligibility is set as September 5, 2026. Annual Report for FY26 is available digitally for all shareholders.

Davangere Sugar revenue rises 11% in FY26; net profit drops 32%

Davangere Sugar reported FY26 total income of ₹24,109.89 lakh, up 11.23% YoY, while net profit fell 31.66% to ₹740.60 lakh due to margin pressures. The company plans to convert ₹40.11 crore of promoter loans into equity warrants, boosting promoter stake to 45.67%. It also seeks approval for a $100 million overseas investment mandate and related party transactions with its UK subsidiary.

Davangere Sugar Q1 Results: Net profit rises 16% YoY to ₹588 crore

Davangere Sugar Company posted a 16% YoY net profit increase to ₹588.24 crore in Q1FY27, driven by higher sugar production volumes of 18,456 tonnes and improved operational margins. Revenue rose 11.2% to ₹1,245.50 crore, with no dividend declared for the quarter.

Davangere Sugar re-appoints D G M S & Co as statutory auditor for five years

Davangere Sugar Company Limited re-appointed M/s. D G M S & Co. as statutory auditor for five years, covering FY27 to FY31. The Board approved the move on August 05, 2026, pending shareholder ratification at the 55th AGM. This constitutes the firm's second consecutive five-year term.

Davangere Sugar Agrees to Convert Loans into Equity Shares or Convertible Warrants

Davangere Sugar Company has agreed to convert loans into equity shares or convertible warrants as part of its capital restructuring. The Board of Directors had convened on July 28, 2026, to consider raising funds through convertible warrants and/or other eligible securities via private placement or preferential issue, in compliance with SEBI and Companies Act regulations, subject to shareholder and regulatory approvals.